Hypersensitivity and Loss of Disease Site Targeting Caused by Antibody Responses to PEGylated Liposomes
Open Access
- 1 February 2006
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 13 (2), 328-337
- https://doi.org/10.1016/j.ymthe.2005.09.014
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Induction of Inflammatory Cytokines and Interferon Responses by Double-stranded and Single-stranded siRNAs is Sequence-dependent and Requires Endosomal LocalizationJournal of Molecular Biology, 2005
- Immunogenicity and Rapid Blood Clearance of Liposomes Containing Polyethylene Glycol-Lipid Conjugates and Nucleic AcidJournal of Pharmacology and Experimental Therapeutics, 2004
- TLR9 signals after translocating from the ER to CpG DNA in the lysosomeNature Immunology, 2004
- Pharmacokinetics of Pegylated Liposomal DoxorubicinClinical Pharmacokinetics, 2003
- Interleukin 15 Controls both Proliferation and Survival of a Subset of Memory-Phenotype CD8+ T CellsThe Journal of Experimental Medicine, 2002
- CpG Motifs in Bacterial DNA and Their Immune EffectsAnnual Review of Immunology, 2002
- Tc-99m-PEG-Liposomes for the Evaluation of Colitis in Crohn's DiseaseJournal of Drug Targeting, 2000
- Accelerated Clearance of Polyethylene Glycol-Modified Proteins by Anti-Polyethylene Glycol IgMBioconjugate Chemistry, 1999
- Thymus-independent antigens: complexity of B-lymphocyte activation revealedImmunology Today, 1982
- Biological stability of [3H]cholesteryl oleyl ether in cultured fibroblasts and intact ratFEBS Letters, 1980